Qingang Tan

Prof. Dr. Qingang Tan

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2020 in Natural Product Research
Verified
Journal Article
Closed access
SZSheng-Nan Zhang
Sheng-Nan Zhang
LHLin Huang
Lin Huang
RMRui-Jing Ma
Rui-Jing Ma
MYMei-Feng Yang
Mei-Feng Yang
BWBen-Fu Wei
Ben-Fu Wei
QTQingang Tan
Qingang Tan
One new long-chain ester derivative of trans-ferulic acid 1 and one natural tirucallane-type triterpenoid 2, together with forty known compounds (3-42), were isolated from the barks of Melia azedarach. Their structures were established on the basis of spectroscopic data interpretation. Compounds 7, 9, 10, 12, 13 showed significant inhibitory activities against PTP1B with IC50 values of 13.82 ± 1.29 μM, 13.29 ± 2.26 μM, 20.27 ± 0.52 μM, 24.36 ± 1.25 μM, 15.23 ± 0.6 μM, respectively.

16 November 2018 in Natural Product Research
Verified
Journal Article
Closed access
JZJin Zeng
Jin Zeng
RMRui-Jing Ma
Rui-Jing Ma
LWLing Wang
Ling Wang
SZSheng-Nan Zhang
Sheng-Nan Zhang
HSHong-Zhi Song
Hong-Zhi Song
QTQingang Tan
Qingang Tan
Six compounds, benzyl 3-O-β-D-glucopyranosyl-7-hydroxybenzoate (1), spathulenol (2), 1,7,8-trihydroxy-2-naphtaldehyde (3), quercetin (4), astragalin (5) and 2-methoxy-4-(2-propenyl)phenyl β-D-glucoside (6), were isolated from the leaves of Melia azedarach L. The structure elucidation of compound 1 was discussed in detail based on its 2D-NMR data. Compound 1 showed weak cytotoxicity against the cell lines of T-24, NCI-H460, HepG2, SMMC-7721, CNE, MDA-MB-231 and B16F10 with the inhibition rates from 10.01% to 34.05% at the concentration of 80 μM.

1 October 2020 in Fitoterapia
Verified
Journal Article
Closed access
SZSheng-Nan Zhang
Sheng-Nan Zhang
HSHong-Zhi Song
Hong-Zhi Song
RMRui-Jing Ma
Rui-Jing Ma
CLCheng-Qin Liang
Cheng-Qin Liang
HWHeng-Shan Wang
Heng-Shan Wang
QTQingang Tan
Qingang Tan

21 September 2021 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
YTYu-Ting Tang
Yu-Ting Tang
JWJing Wu
Jing Wu
YYYang Yu
Yang Yu
MBMei-Fen Bao
Mei-Fen Bao
QTQingang Tan
Qingang Tan
XCXiang-Hai Cai
Xiang-Hai Cai

12 March 2022 in Phytochemistry
Verified
Journal Article
Closed access
YTYu-Ting Tang
Yu-Ting Tang
JWJing Wu
Jing Wu
MBMei-Fen Bao
Mei-Fen Bao
QTQingang Tan
Qingang Tan
XCXiang-Hai Cai
Xiang-Hai Cai

28 December 2021 in Planta Medica
Verified
Journal Article
Closed access
PDF file
HSHongzhi Song
Hongzhi Song
JTJinni Tan
Jinni Tan
RMRuijing Ma
Ruijing Ma
Edward James KennellyEdward James Kennelly
Edward James Kennelly
QTQingang Tan
Qingang Tan
Caulis Trachelospermi, the stems with leaves of Trachelospermum jasminoides, is a well-known herbal drug of the Apocynaceae family recorded in the Chinese pharmacopeia and used for the treatment of inflammation-related diseases by ethnic minorities of China. The mechanism of anti-inflammatory activity and responsible constituents of T. jasminoides have not been well elucidated in previous studies. Preliminary investigation showed that both the water and the ethyl ester extracts of T. jasminoides exhibited potent inhibitory activity on nitric oxide (NO) production using lipopolysaccharide (LPS)-stimulated murine macrophages. Phytochemical investigation on these extracts afforded 23 compounds, including three new compounds (1 –3) identified on the basis of spectroscopic and mass spectrometric data. Anti-inflammatory bioassay showed that compounds 17, 18, 22, and 23 inhibited significantly the production of NO in a concentration-dependent manner. Further studies indicated that compound 23 inhibited significantly TNF-α and IL-6 produced by LPS-stimulated RAW 264.7 cells with good selectivity, as well as protein expression of iNOS in RAW 264.7 cells. These chemical constituents may contribute to the anti-inflammatory potential of T. jasminoides. # Dedicated to Professor Dr. Douglas Kinghorn on the occasion of his 75th birthday. Received: 12 September 2021 Accepted after revision: 25 November 2021 Publication Date: 28 December 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany